Celularity Regains Compliance with Nasdaq Listing Requirements
Celularity (CELU) has received official written confirmation from Nasdaq that it is once again in compliance with the exchange's periodic reporting requirements. The company had previously faced a non-compliance notice due to delays in filing its required financial reports with the U.S. Securities and Exchange Commission. The matter was resolved following Celularity's submission of its Quarterly Report on Form 10-Q for the period ending June 30, 2026. With this filing, Nasdaq has formally closed the reporting deficiency case, removing the immediate threat of delisting related to these specific regulatory delays.
Topics: Nasdaq compliance reporting deficiency SEC filings
Read the full article at Seeking Alpha
Part of the story Celularity Regains Compliance with Nasdaq Listing Requirements (2 articles)